{"id":570345,"date":"2010-05-19T12:33:40","date_gmt":"2010-05-19T16:33:40","guid":{"rendered":"http:\/\/www.xconomy.com\/?p=80804"},"modified":"2010-05-19T12:33:40","modified_gmt":"2010-05-19T16:33:40","slug":"arsenal-medical-startup-linked-to-langer-and-whitesides-adds-10m","status":"publish","type":"post","link":"https:\/\/mereja.media\/index\/570345","title":{"rendered":"Arsenal Medical, Startup Linked to Langer and Whitesides, Adds $10M"},"content":{"rendered":"\n<div style=\"text-transform:uppercase\"><a href=\"http:\/\/www.xconomy.com\/tag\/Life-Sciences\/\">Life Sciences<\/a>, <a href=\"http:\/\/www.xconomy.com\/tag\/deals\/\">deals<\/a>, <a href=\"http:\/\/www.xconomy.com\/tag\/startups\/\">startups<\/a><\/div>\n<p>\t\t<a rel=\"attachment wp-att-80815\" href=\"http:\/\/www.xconomy.com\/?attachment_id=80815\"><img loading=\"lazy\" decoding=\"async\" style=\"float:right;margin: 0px 0 5px 15px;\" class=\"alignnone size-thumbnail wp-image-80815\" title=\"arsenal logo\" src=\"http:\/\/www.xconomy.com\/wordpress\/wp-content\/images\/2010\/05\/arsenal1-180x74.png\" alt=\"arsenal logo\" width=\"180\" height=\"74\" \/><\/a><br \/>\n\t\t<strong>Ryan McBride wrote:<\/strong><\/p>\n<p>Arsenal Medical, a stealthy biotech startup based in Watertown, MA, has tapped its existing base of investors to pump in another $10 million in the second installment of its Series C round of funding, R. Scott Rader, the company&#8217;s CEO, says. The financing, which was initially revealed in an SEC <a href=\"http:\/\/www.sec.gov\/Archives\/edgar\/data\/1327273\/000132727310000003\/xslFormDX01\/primary_doc.xml\">filing<\/a> that went online yesterday, brings the firm&#8217;s third round to $18.2 million.<\/p>\n<p>Investors in the latest round included North Bridge Venture Partners and Polaris Venture Partners, both of Waltham, MA, as well as Durham, NC-based Intersouth Partners, Rader says. The developer of bioactive materials has raised nearly $41 million since its launch, the CEO says. He declined to discuss the specific purpose of the latest financing.<\/p>\n<p>Arsenal has generated buzz for its big-name founders, most notably Bob Langer, the MIT inventor of acclaimed drug-delivery technologies, and the standout Harvard chemist and Genzyme (NASDAQ:<a href=\"http:\/\/finance.yahoo.com\/q?s=GENZ\">GENZ<\/a>) co-founder George Whitesides. <a href=\"http:\/\/www.xconomy.com\/boston\/2009\/05\/14\/arsenal-medical-cto-jeff-carbeck-on-his-secretive-startup-attractions-of-clean-energy-sector\/2\/\">Jeff Carbeck, Arsenal&#8217;s co-founder and former chief technology officer<\/a>, provided a few details about the firm&#8217;s technology last year. Carbeck says that Arsenal&#8217;s chairman and co-founder, Carmichael Roberts, recruited him to help build the startup. Roberts is a partner at North Bridge and a former member of Whitesides&#8217;s lab at Harvard.<\/p>\n<p>Arsenal (formerly WMR Biomedical)\u00a0 provides additional information about its &#8220;bioactive composites&#8221; on its <a href=\"http:\/\/www.arsenalmedical.com\/composites\/index.html\">website<\/a>. It highlights its &#8220;ElastaCore&#8221; biomaterial, which can provide some of the strength of metal while still allowing the body to absorb it. Also, the firm touts its &#8220;AxioCore&#8221; technology, which is another absorbable material that is designed to provide controlled release of drugs.<\/p>\n<p>Rader says that the company might shed more light on its technology in the near future.<\/p>\n<div class=\"postFooter\"><a href=\"http:\/\/www.xconomy.com\/boston\/2010\/05\/19\/arsenal-medical-startup-linked-to-langer-and-whitesides-adds-10m\/#comments\">Comments<\/a> | <a href=http:\/\/www.xconomy.com\/reprints\/>Reprints<\/a> | Share: &nbsp;<br \/>\n<a href=\"http:\/\/twitter.com\/home?status=RT%20@Xconomy%20Arsenal%20Medical,%20Startup%20Linked%20to%20Langer%20and%20Whitesides,%20Adds%20$10M%20http:\/\/xconomy.com\/?p=80804\"  rel=\"nofollow\"><img decoding=\"async\" src=\"http:\/\/www.xconomy.com\/wordpress\/wp-content\/themes\/xconomy\/images\/twitter.gif\" alt=\"Retweet\"\/><\/a><br \/>\n&nbsp;<a href=\"http:\/\/www.facebook.com\/sharer.php?u=http:\/\/www.xconomy.com\/boston\/2010\/05\/19\/arsenal-medical-startup-linked-to-langer-and-whitesides-adds-10m\/&#038;t=Arsenal%20Medical,%20Startup%20Linked%20to%20Langer%20and%20Whitesides,%20Adds%20$10M\"  rel=\"nofollow\"><img decoding=\"async\" src=\"http:\/\/www.xconomy.com\/wordpress\/wp-content\/themes\/xconomy\/images\/facebook.gif\" alt=\"Facebook\"\/><\/a><br \/>\n&nbsp;<a href=http:\/\/www.xconomy.com\/boston\/2010\/05\/19\/arsenal-medical-startup-linked-to-langer-and-whitesides-adds-10m\/email\/  rel=\"nofollow\"><img decoding=\"async\" src=\"http:\/\/www.xconomy.com\/wordpress\/wp-content\/themes\/xconomy\/images\/email.gif\" alt=\"Email\"\/><\/a><br \/>\n&nbsp;<a href=\"http:\/\/sharethis.com\/item?publisher=bfda184d-6684-4f7a-a23f-ca4ed4db9287&amp;title=Arsenal+Medical%2C+Startup+Linked+to+Langer+and+Whitesides%2C+Adds+%2410M&amp;url=http%3A%2F%2Fwww.xconomy.com%2Fboston%2F2010%2F05%2F19%2Farsenal-medical-startup-linked-to-langer-and-whitesides-adds-10m%2F\"><img decoding=\"async\" src=\"http:\/\/www.xconomy.com\/wordpress\/wp-content\/themes\/xconomy\/images\/share.gif\" alt=\"Share\"\/><\/a>\n<\/div>\n<p>\t     \t\t\t<!-- ad options: 2621  --><br \/>\n\t\t\t\t\t\t<br \/>\n\t\t\t<a href='http:\/\/d.xconomy.com\/ck.php?bannerid=262' ><br \/>\n\t\t\t<img src='http:\/\/d.xconomy.com\/avw.php?bannerid=262&amp;cb=697' border='0' alt='' \/><\/a><br \/>\n\t\t\t<br \/>\n\t\t\t\t<br clear=\"both\" style=\"clear: both;\"\/><br \/>\n<br clear=\"both\" style=\"clear: both;\"\/><br \/>\n<a href=\"http:\/\/ads.pheedo.com\/click.phdo?s=a54a616aa4201fcd2086704828e10431&#038;p=1\"><img decoding=\"async\" alt=\"\" style=\"border: 0;\" border=\"0\" src=\"http:\/\/ads.pheedo.com\/img.phdo?s=a54a616aa4201fcd2086704828e10431&#038;p=1\"\/><\/a><br \/>\n<img loading=\"lazy\" decoding=\"async\" alt=\"\" height=\"0\" width=\"0\" border=\"0\" style=\"display:none\" src=\"http:\/\/a.triggit.com\/px?u=pheedo&#038;rtv=Business&#038;rtv=p29917&#038;rtv=f21595\"\/><img loading=\"lazy\" decoding=\"async\" alt=\"\" height=\"0\" width=\"0\" border=\"0\" style=\"display:none\" src=\"http:\/\/pixel.quantserve.com\/pixel\/p-8bUhLiluj0fAw.gif?labels=pub.29917.rss.Business.21595,cat.Business.rss\"\/><\/p>\n<p><a href=\"http:\/\/feedads.g.doubleclick.net\/~a\/Ft9dY8CTsVuFaKougaZhCS-rW0k\/0\/da\"><img decoding=\"async\" src=\"http:\/\/feedads.g.doubleclick.net\/~a\/Ft9dY8CTsVuFaKougaZhCS-rW0k\/0\/di\" border=\"0\" ismap=\"true\"><\/img><\/a><br \/>\n<a href=\"http:\/\/feedads.g.doubleclick.net\/~a\/Ft9dY8CTsVuFaKougaZhCS-rW0k\/1\/da\"><img decoding=\"async\" src=\"http:\/\/feedads.g.doubleclick.net\/~a\/Ft9dY8CTsVuFaKougaZhCS-rW0k\/1\/di\" border=\"0\" ismap=\"true\"><\/img><\/a><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" src=\"http:\/\/feeds.feedburner.com\/~r\/Xconomy_Full\/~4\/HX9hLCX0mWg\" height=\"1\" width=\"1\"\/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Life Sciences, deals, startups Ryan McBride wrote: Arsenal Medical, a stealthy biotech startup based in Watertown, MA, has tapped its existing base of investors to pump in another $10 million in the second installment of its Series C round of funding, R. Scott Rader, the company&#8217;s CEO, says. The financing, which was initially revealed in [&hellip;]<\/p>\n","protected":false},"author":2829,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[],"class_list":["post-570345","post","type-post","status-publish","format-standard","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/570345","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/users\/2829"}],"replies":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/comments?post=570345"}],"version-history":[{"count":0,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/570345\/revisions"}],"wp:attachment":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/media?parent=570345"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/categories?post=570345"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/tags?post=570345"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}